Signify Premium Insight: HeartFlow’s Death-Defying Claims
Published: October 5, 2023
The European Society of Cardiology Congress meeting in Amsterdam enjoyed the presentation of the two-year results of the FISH&CHIPS study, a real world, multi-centre, retrospective clinical study of 90,553 National Health Service (NHS) patients.
The study assessed the impact of the use of HeartFlow’s FFR-CT evaluation and diagnosis of coronary artery disease, a solution that, for some patients, can avoid invasive catheterisation processes which would otherwise have been used.
The two-year outcomes of the study were very positive, with key outcomes including:
- A 14% relative reduction in cardiovascular mortality and 8% relative reduction in all-cause mortality.
- An increase in cath lab efficiency driven by a 5% relative reduction in invasive cardiac angiography and an 8% relative increase in Percutaneous Coronary Intervention.
- A 14% relative reduction in additional non-invasive heart testing.
Read the full insight with a Signify Premium Insights – Medical Imaging subscriptionSign up for a free trial today.
AI in Medical Imaging Market Intelligence ServiceOngoing series of reports, data and insights delivered over the year
AI in Medical Imaging Market Intelligence Service
This Market Intelligence Service provides regular data, insights and analysis on the global market opportunity for AI-based medical image analysis.
Find out more